Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Maria Angeliki Dimopoulou"'
Autor:
Georgios Georgiopoulos, Dimitrios Delialis, Evmorfia Aivalioti, Vasileios Georgakis, Georgios Mavraganis, Lasthenis Angelidakis, Dimitrios Bampatsias, Elena Armeni, Eleni Maneta, Raphael Patras, Maria Angeliki Dimopoulou, Ermioni Oikonomou, Ioannis Kanakakis, Irene Lambrinoudaki, Areti Lagiou, Panos Xenos, Kimon Stamatelopoulos
Publikováno v:
Hellenic Journal of Cardiology, Vol 73, Iss , Pp 16-23 (2023)
Objective: Sex-specific data are limited regarding eligibility for hypolipidemic treatment. We aim to explore the sex-specific clinical utility of high-sensitivity C-reactive protein (hsCRP) and carotid ultrasound as risk modifiers for hypolipidemic
Externí odkaz:
https://doaj.org/article/4bc35e4fc5314f4eaf409ba266530a5d
Autor:
Dimitrios Bampatsias, Maria-Angeliki Dimopoulou, Dimitrios Karagiannakis, Alexandros Sianis, Eleni Korompoki, Kanella Kantreva, Erasmia Psimenou, Georgia Trakada, George Papatheodoridis, Kimon Stamatelopoulos
Publikováno v:
Journal of Clinical Lipidology. 17:219-224
Autor:
Kimon Stamatelopoulos, Dimitrios Delialis, Maria-Angeliki Dimopoulou, Maria Papaioannou, Georgia Kotsira, Eleni Maneta, Georgios Mavraganis, Christos Loutos, GEORGIOS GEORGIOPOULOS
Publikováno v:
Current Pharmaceutical Design. 29
Abstract: Proprotein convertase subtilisin/kexin type 9 inhibitors (PCSK9i) represent a novel class of hypolipidemic drugs, providing an additional therapeutic option over conventional hypolipidemic treatments. Given the constantly lowering recommend
Autor:
Georgios Mavraganis, Maria‐Angeliki Dimopoulou, Dimitrios Delialis, Dimitrios Bampatsias, Raphael Patras, Alexandros Sianis, Eleni Maneta, Kimon Stamatelopoulos, Georgios Georgiopoulos
Publikováno v:
European journal of clinical investigationREFERENCES. 52(11)
Accumulating evidence suggests that endothelial dysfunction is implicated in the pathogenesis and severity of coronavirus disease 2019 (COVID-19). In this context, vascular impairment in COVID-19 might be associated with clinical manifestations and c
Autor:
Georgios Georgiopoulos, Georgios Mavraganis, Dimitrios Delialis, Stelios Georgiou, Evmorfia Aivalioti, Raphael Patras, Ioannis Petropoulos, Maria-Angeliki Dimopoulou, Lasthenis Angelidakis, Alexandros Sianis, Dimitrios Bampatsias, Anna Dimoula, Eleni Maneta, Marinos Kosmopoulos, Constantine Vardavas, Konstantinos Stellos, Kimon Stamatelopoulos
Publikováno v:
European journal of preventive cardiology. 29(13)
Aims The clinical value of carotid atherosclerosis markers for residual risk stratification in high atherosclerotic cardiovascular disease (ASCVD) risk patients is not established. We aimed to derive and validate optimal values of markers of carotid